{"id":"W2980603063","doi":"10.1111/bjd.18623","title":"Secukinumab for patients failing previous tumour necrosis factor‐α inhibitor therapy: results of a randomized open‐label study (SIGNATURE)","year":2019,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"Novartis Pharmaceuticals UK Limited","keywords":"Secukinumab; Medicine; Randomized controlled trial; Oncology; Open label; Tumor necrosis factor alpha; Signature (topology); Internal medicine; Necrosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004216254,0.001285866,0.003516776,0.0003761527,0.000351541,0.0008461564,0.0005753282,0.00129254,0.004143736],"category_scores_gemma":[0.003229726,0.0005167902,0.002160967,0.0004644186,0.00116327,0.0008910652,0.000368758,0.001405964,0.0006538738],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006984337,"about_ca_system_score_gemma":0.001268196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004994591,"about_ca_topic_score_gemma":0.0009272639,"domain_scores_codex":[0.9982722,0.001081841,0.0001340713,0.0001940273,0.0001491848,0.0001685596],"domain_scores_gemma":[0.996663,0.0009637531,0.0008720703,0.0003741635,0.0002593379,0.0008676082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.963715,0.009822417,0.003339623,0.0003586857,0.0009520972,0.00004561575,0.00006117822,0.0002356594,0.002929877,0.00003464239,0.0003973143,0.01810785],"study_design_scores_gemma":[0.8322924,0.1560073,0.009569709,0.00003090287,0.0007340861,0.00008236673,0.00002520046,0.0003512333,0.0004764616,0.00004671538,0.0003652014,0.00001839669],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968419,0.001017753,0.0002144645,0.0001374321,0.00007473871,0.0009625004,0.0003834993,0.00003305096,0.0003345891],"genre_scores_gemma":[0.9944592,0.001039859,0.0008929831,0.0004114675,0.0002303534,0.001415277,0.001012368,0.00001323982,0.0005253914],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004216254,"threshold_uncertainty_score":0.02229792,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01862450544848062,"score_gpt":0.264304644580543,"score_spread":0.2456801391320624,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}